CANF
Can-Fite BioPharma
CANF
CANF
12 hedge funds and large institutions have $1.35M invested in Can-Fite BioPharma in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
75% less capital invested
Capital invested by funds: $5.35M → $1.35M (-$4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
12
Holding in Top 10
–
Calls
$25K
Puts
–
Top Buyers
| 1 | +$50K | |
| 2 | +$41K | |
| 3 | +$12K | |
| 4 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
+$9K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$5.88K |
Top Sellers
| 1 | -$1.96M | |
| 2 | -$1.32M | |
| 3 | -$352K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$15K |
| 5 |
WWM
Wagner Wealth Management
Greenville,
South Carolina
|
-$4K |